BioServe

Beltsville, United States Founded: 1989 • Age: 37 yrs
Provides biorepositories and preclinical molecular services.

About BioServe

BioServe is a Healthcare company based in Beltsville (United States) founded in 1989. It provides biorepositories and preclinical molecular services. It operates on a B2B model. BioServe has completed 1 acquisition, including Genomics Collaborative. Its focus areas include Biotechnology, Research Services and Molecular and Preclinical. Its legal entity is BIOSERVE BIOTECHNOLOGIES, LTD. Its competitors include Omniome, Genewiz and Singular Genomics; 1 of its 3 listed competitors has raised funding.

Company details

BioServe provides biorepositories and preclinical molecular services through providing healthcare solutions, advancing biotech innovations, research services, and molecular and preclinical. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Beltsville, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bioserve.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Bioserve Biotechnologies, Ltd
Key Metrics

Funding Insights of BioServe

  • Total Rounds 4
  • Investors Count 3

All 4 funding rounds of BioServe with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2007Unspecified––
Jun 1994Grant––
Jun 1993Grant––
Oct 1989Unspecified––
Valuation history

3 investors in total: 3 institutional.

Investors in BioServe

BioServe has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include SBIR, Ventureast and University of Maryland Global Campus.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital investments in technology, healthcare, and clean environment sectors since 1997.
1997ventureast.netBengaluru, India
Federal innovation and scientific achievement services are provided.
1982sbir.govLithia Springs, United States
Multiple courses and degrees are offered across diversified streams.
1947umgc.eduLargo, United States
Premium access

Investor details for BioServe

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BioServe

14 people are tracked at BioServe (7 in leadership, 6 in board & advisors, 1 in team).

NameRoleGroup
Chikafumi Yokoyama
CEOLeadership
Rama Modali
CEO, REPROCELL USALeadership
David Bunton
CEO, REPROCELL EuropeLeadership
Daisuke Usui
Chief Operating OfficerLeadership
Yoshiyuki Yamakawa
DirectorLeadership
Ejaz Ansari
Laboratory Manager & Study DirectorLeadership
Graeme Macluskie
Precision Medicine DirectorLeadership
Norio Nakatsuji
AdviserBoard & advisors
Hiromitsu Nakauchi
AdviserBoard & advisors
Hiroyuki Mizuguchi
AdviserBoard & advisors
Wado Akamatsu
AdviserBoard & advisors
Hiroshi Yagi
AdviserBoard & advisors
Taeko Naruse
AdviserBoard & advisors
Bob Annand
Senior Technical Product ManagerTeam
Premium access

Complete people profiles for BioServe

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BioServe

BioServe has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Genomics Collaborative.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Collaborative genomics research services are provided since 2014.
genomicsinc.com2014May 2007$2M
Premium access

Complete acquisition details for BioServe

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of BioServe

4 dated milestones of BioServe across 18 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioServe is founded.
  2. Funding First funding round.
  3. Acquisition Acquires Genomics Collaborative.
  4. Funding Latest funding round, Unspecified,.

Competitors of BioServe

BioServe has 3 listed competitors in our database, 1 of them funded. They include Omniome, Genewiz and Singular Genomics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
omniome.com2013San Diego, United States$160.23M164
Genome sequencing platform is provided for clinical diagnostics.
genewiz.com1999South Plainfield, United States452
Genomic services are provided for the life sciences industry.
singulargenomics.com2016San Diego, United States169
Next-generation gene sequencing and multi-omics technologies are provided.
Premium access

Detailed competitors of BioServe

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of BioServe

Websites that share an audience with BioServe (bioserve.com).

Similar websites

Websites whose visitors overlap most with BioServe. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
lamdabio.com
100%
View details
genedx.com
85%
129.4K#317,801View details
genwaybio.com
76%
View details
cybrdi.com
64%
View details

Top companies in Clinical Trials & Research Tech

3 companies that operate in the same segment as BioServe (Clinical Trials & Research Tech) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Genetic services are provided by Colossal's laboratory operations.
2021Austin, Texas, United StatesUSD 619.8 M252
Research lab engaged in pharmacological measurements on therapeutic protein variants
2018United StatesUSD 78.19 M22
Medical research labs are provided by GALY for scientific purposes.
2018Boston, Massachusetts, United StatesUSD 61.59 M25
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bioserve

Premium access

Complete news archive for BioServe

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioServe

BioServe was founded in 1989.

BioServe is headquartered in Beltsville, United States. It is registered at Beltsville, Maryland, United States.

BioServe provides biorepositories and preclinical molecular services through providing healthcare solutions, advancing biotech innovations, research services, and molecular and preclinical. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

BioServe's top competitors include Singular Genomics, Omniome and Genewiz.

BioServe has made 1 acquisition, including Genomics Collaborative.

BioServe has 3 investors. Key investors include SBIR, Ventureast, and University of Maryland Global Campus.

BioServe operates through Bioserve Biotechnologies, Ltd.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available